93199-8LOINC 2.82
DPYD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
DPYD gene Mut Anl Bld/T
Definition
- The test includes targeted analysis of variants in the DPYD gene by various molecular pathology methods, including PCR and sequencing. Testing may be performed to identifying individuals at increased risk of toxicity when considering 5-fluorouracil (5-FU) and capecitabine chemotherapy treatment. Variations detected in the DPYD gene are also associated with dihydropyrimidine dehydrogenase (DPD) deficiency.
Component
- DPYD gene targeted mutation analysis
Specimen / system
- Bld/Tiss
Class
- MOLPATH.PHARMG
Property
- Find
Scale
- Doc
Method
- Molgen
Related names
- Blood; DHP; DHPDHase; dihydropyrimidine dehydrogenase; Dihydropyrimidine dehydrogenase gene; Dihydrothymine dehydrogenase gene; Dihydrouracil dehydrogenase gene; Document; DPD; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue
Index terms
- Blood
- DHP
- DHPDHase
- dihydropyrimidine dehydrogenase
- Dihydropyrimidine dehydrogenase gene
- Dihydrothymine dehydrogenase gene
- Dihydrouracil dehydrogenase gene
- Document
- DPD
- Finding
- Findings
- Molecular genetics
- Molecular pathology
- MOLPATH
- MOLPATH.PHARMG
- Mut
- Mut Anl
- Mutations
- PCR
- Point in time
- Random
- Tissue
- Tissue, unspecified
- WB
- Whole blood
- Whole blood or Tissue